Researchers Develop Device To Predict Diabetic Wound Healing

From Medical News Today (see http://mnt.to/f/3D4f):

“Complex wounds affect more patients in the United States than heart attack and stroke combined, and five to seven million Americans with complex wounds account for over $20 billion in healthcare expenditures. About 150,000 amputations a year result from complex wounds, while about 80,000 are attributed to diabetes and peripheral arterial disease…”

“A new breakthrough device developed by researchers can change the current landscape of chronic wound management. Researchers at Drexel University’s School of Biomedical Engineering, Science and Health Systems developed a prototype device that measures the level of oxygenated and deoxygenated hemoglobin within and under a wound and compares it to a control/non-wound site of the same patient. Based on a human study at the Wound Clinic of the Drexel College of Medicine, the time course of oxygenated hemoglobin change was found to be a strong indicator of wound healing.”

While there is a large market for products in wound management, with a significant share of it being in mostly traditional dressings and bandages, the highest growth in wound management technologies is in areas that focus on the high cost chronic or slow-healing wounds. Technologies like negative pressure wound therapy and a wide range of physical wound therapy systems represent big growth opportunities since they promise to hasten healing and thereby reduce the overall cost of treating these wound types. (See MedMarket Diligence Report #S247, “Worldwide Wound Management Market, 2008-2017“, http://mediligence.com/rpt/rpt-s247.htm.)

Posted via email from medmarket’s posterous